The Next Big Player in Supplements


First published on

Aug 27, 2014

I’m confident genetic-based personalized medicine will be a massive part of the industry over the next 20 years. Quality will still be a critical success factor, hopefully made simpler and less expensive by new technologies. I don’t know what to expect from the regulatory side. Since FDA seems to respond to hysteria so quickly, it’s hard to tell what a handful of future, serious adverse events or recalls might produce. Maybe clinical studies will decrease in cost and allow our industry to make new claims. I hope there are some new botanicals discovered, and their properties put to use.

Elan Sudberg


Categories: News & Events